Crinetics Pharmaceuticals (CRNX)
(Real Time Quote from BATS)
$48.99 USD
+0.36 (0.74%)
Updated May 24, 2024 12:32 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.86 | 0.48% |
Earnings Summary
For their last quarter, Crinetics Pharmaceuticals (CRNX) reported earnings of -$0.93 per share, missing the Zacks Consensus Estimate of -$0.84 per share. This reflects a negative earnings surprise of 10.71%. Look out for CRNX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.86 per share, reflecting a year-over-year increase of 8.51%.
Earnings History
Price & Consensus
Zacks News for CRNX
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
CRNX: What are Zacks experts saying now?
Zacks Private Portfolio Services